Searchable abstracts of presentations at key conferences in endocrinology

ea0063p6 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Adrenal insufficiency secondary to bilateral adrenal diffuse large B-cell lymphoma: a case report

Garcia Maria Laura , Speroni Romina , Lisdero Ana Paula

Introduction: Primary adrenal lymphoma is extremely rare. It accounts for <1% of extranodal lymphoma. It affects typically old males with bilateral adrenal gland involvement that leads to adrenal hypofunction. Prognosis is very poor due to the lack of optimum chemotherapeutic regimens.Case Report: A 71 yearr old man with prior history of non insulin dependent diabetes, was admitted to the emergency department with symptoms of progressive weakness, fa...

ea0063p349 | Thyroid 1 | ECE2019

Collision tumor: A case report of tall cell variant of papillary thyroid carcinoma and laryngeal squamous cell carcinoma

Garcia Maria Laura , Lisdero Ana Paula , Szuman Gabriela , Endelman Marta , Castelletti Natalia

Collision tumors (CT) refers to the coexistence of two histologically distinct malignant tumors within the same mass. CT involving the thyroid gland (TG) and/or the neck are specially uncommon and present a diagnostic and treatment challenge.Case report: A 69-year-old male presented with a one year history of bilateral cervical lymph node growth, a four-month history of progressive dysphagia and a dyspnea associated with a rapidly expanding, painless mas...

ea0070ep113 | Bone and Calcium | ECE2020

Zoledronic acid treatment in women with postmenopausal osteoporosis; A cohort follow–up.

García María Laura , Lisdero Ana Paula , Speroni Romina , Segarra Ana , Otero Jimena , Benito Camila , Giselle Mumbach Aizhar

Zoledronic acid (ZA) treatment increases bone mineral density (BMD), decreases bone turnover markers and reduces the risk of fractures in patients with osteoporosis (1).Objective: Observe and quantify the changes in BMD and bone turnover markers in postmenopausal osteoporosis (PO) patients treated annually with zoledronic acid 5 mg intravenously.Material and Methods: Medical records (MR) of PO patients whom received ZA from 2007 to...

ea0081ep197 | Calcium and Bone | ECE2022

Correlation between vitamin D levels and severity of COVID 19 disease. Argentine Experience

Garcia Maria Laura , Lisdero Ana Paula , Giacoia Evangelina , Lopez Franco , Cruceno Mauro , Pollini Valeria , Esposito Marcia , Scarabino Mariana , Bacigaluppi Susana , Mumbach Aizhar Giselle

Objective Vitamin D (VD) plays a role in immune response. Recent data shows that low levels of VD could worsen COVID-19 outcomes. This study aimed to establish an association between VD levels among COVID-19 patients with clinical outcomes and inflammatory markers.Methods Prospective multicentric cohort study. Consecutively recruitment. Patients were grouped according admission status and level of VD [sufficient >30 ng/ml (VDS), insufficient 20–...

ea0073pep15.5 | Presented ePosters 15: Late Breaking | ECE2021

Pheochromocytoma secreting IL-6; an atypical presentation

Laura García María , Lisdero Ana Paula , González Pernas Mariana , Speroni Romina , Segarra Ana , Otero Jimena , Genovesi Elbio , Belli Susana , Giselle Mumbach Aizhar

Pheochromocytoma (PCC) is a rare tumor that arises from the adrenal medulla, usually presents with headache, sweating and palpitations due to excessive catecholamine release. However, PCC may secrete neuropeptides, hormones and cytokines, such as interleukin-6 (IL-6)) resulting in unusual clinical manifestations. A 48-year-old woman with a previous history of type 1 neurofibromatosis (NF1) and hypertension was referred to discarded PCC. Laboratory tests revealed leukocytosis a...